Health Care & Life Sciences » Biotechnology | Aratana Therapeutics Inc.

Aratana Therapeutics Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
45,754.00
98,072.00
86,202.00
88,303.00
67,615.00
42,671
Total Accounts Receivable
1,001.00
352.00
60.00
87.00
2,406.00
2,204
Inventories
55.00
427.00
1,306.00
11,130.00
13,576.00
11,425
Other Current Assets
1,655.00
1,058.00
1,451.00
2,022.00
1,642.00
1,827
Total Current Assets
48,465.00
99,909.00
89,019.00
101,542.00
85,239.00
58,127
Net Property, Plant & Equipment
98.00
620.00
2,555.00
1,948.00
1,166.00
693
Total Investments and Advances
-
2,452.00
350.00
350.00
350.00
351
Intangible Assets
66,936.00
103,721.00
54,848.00
47,021.00
47,911.00
46,945
Other Assets
37.00
1,201.00
294.00
545.00
526.00
320
Total Assets
115,536.00
207,903.00
147,066.00
151,406.00
135,192.00
106,436
ST Debt & Current Portion LT Debt
8,625.00
-
-
14,413.00
17,333.00
Accounts Payable
2,307.00
1,532.00
1,400.00
7,436.00
7,451.00
Income Tax Payable
-
413.00
-
-
-
Other Current Liabilities
5,969.00
7,523.00
4,284.00
12,839.00
10,712.00
Total Current Liabilities
16,901.00
9,468.00
5,684.00
34,688.00
35,496.00
Long-Term Debt
9,310.00
14,963.00
39,710.00
25,775.00
19,492.00
Provision for Risks & Charges
1,543.00
-
-
-
-
Deferred Taxes
1,666.00
1,610.00
-
-
-
Other Liabilities
75.00
30.00
122.00
540.00
70.00
Total Liabilities
29,495.00
26,071.00
45,516.00
61,003.00
55,058.00
Common Equity (Total)
86,041.00
181,832.00
101,550.00
90,403.00
80,134.00
Total Shareholders' Equity
86,041.00
181,832.00
101,550.00
90,403.00
80,134.00
Total Equity
86,041.00
181,832.00
101,550.00
90,403.00
80,134.00
Liabilities & Shareholders' Equity
115,536.00
207,903.00
147,066.00
151,406.00
135,192.00

About Aratana Therapeutics

View Profile
Address
11400 Tomahawk Creek Parkway
Leawood Kansas 66211
United States
Employees -
Website http://www.aratana.com
Updated 07/08/2019
Aratana Therapeutics, Inc. operates as a development stage biopharmaceutical company, which focuses on the licensing, development and commercialization of innovative prescription medications for pets or pet therapeutics. It delivers prescription medicines that address significant medical needs for cats and dogs. The firm licenses proprietary, patent-protected compounds from human pharmaceutical and biotechnology companies.